Aurinia Pharmaceuticals(AUPH) - 2024 Q3 - Quarterly Results

Exhibit 99.1 Aurinia Pharmaceuticals Reports Third Quarter and Nine Months 2024 Financial and Operational Results, Announces Strategic Restructuring to Sharpen Focus on Continued LUPKYNIS Growth and AUR200 Development ® • Achieved $67.8 million in total net revenue and $55.5 million in net product revenue for the third quarter of 2024, representing year-over-year growth of 24% and 36%, respectively • Generated $17.0 million in cash flow from operations in the third quarter and had cash, cash equivalents, re ...